Background: A novel approach to determine vitamin B 12 status is to combine four blood markers: total B 12 (B 12 ), holotranscobalamin (holoTC), methylmalonic acid (MMA) and total homocysteine (tHcy). This combined indicator of B 12 status is expressed as cB 12 = log 10 [(holoTC·B 12 )/ (MMA·Hcy)]-(age factor). Here we calculate cB 12 in datasets with missing biomarkers, examine the influence of folate status, and revise diagnostic cut-points. Methods: We used a database with all four markers (n = 5211) plus folate measurements (n = 972). A biomarker Z (assumed missing) was plotted versus X (a combination of other markers) and Y (age). Each chart was approximated by a function Z theor , which predicted the potentially absent value(s). Statistical distributions of cB 12 were aligned with physiological indicators of deficiency and used to determine cut-offs. Results: The predictive functions Z theor allowed assessment of the "incomplete" indicators, 3cB 12 (three markers known) and 2cB 12 (two markers known). Predictions contained a systematic deviation associated with dispersion along two axes Z and X (and unaccounted by the least squares fit). Increase in tHcy at low serum folate was corrected (cB 12 +Δ folate ) based on the function of
Introduction
Vitamin B 12 (cobalamin, Cbl) and folate are essential micronutrients for humans [1, 2] . Dietary B 12 mainly comes from animal source foods, whereas folate is primarily of plant origin. In many countries folic acid is added to food staples for neural tube defect prevention. The absorption of dietary B 12 may be insufficient among older adults due to reduced production of gastric intrinsic factor and low gastric acid secretion [3] . Deficiency in either of the two B-vitamins is associated with hematological disorders and neurological alterations of varying severity [4] .
Vitamin B 12 status is assessed predominantly by total serum B 12 , due to the simplicity of the method and its low cost [5] . However the sensitivity of this method in early stages of deficiency is questionable [5] [6] [7] [8] , and the specificity of low serum B 12 for diagnosing diminished B 12 status is also poor. It is also possible to measure the substrates of Cbl-dependent reactions, namely methylmalonic acid (MMA) and total homocysteine (tHcy), whose levels in serum are inversely associated with total B 12 concentrations [6] [7] [8] . The interpretation of metabolite measurements is, however, not straightforward because tHcy also increases with low folate status, and both tHcy and MMA are elevated as a result of impaired renal function [9, 10] .
More recently the Cbl-saturated form of the specific transport protein, holoTC, has been used as an indicator of B 12 status with somewhat better predictive accuracy than total B 12 [11, 12] . In general, B 12 deficiency is expected to result in low concentrations of total B 12 and holoTC, accompanied by high MMA and tHcy. The aforementioned biomarkers are considered to be early (pre-clinical) indicators of deficiency. However, diagnosis is often contradictory when based on the four tests independently [5, 8, 9, 11, [13] [14] [15] [16] [17] .
For this reason efforts have been made to improve the biochemical assessment of B 12 status. Most methods use algorithms with a sequential selection (if → then) based on the conventional cut-point for each marker [18, 19] . The ratio of holotranscobalamin (holoTC)/B 12 (a twocomponent marker) showed a higher predictive potential than each single marker separately [20] . Most recently, we developed a novel approach to combine all four biomarkers and thereby increase precision of diagnosis [21] . The metabolic fingerprint of each subject was presented as either a point on a "diagnostic surface" or a single parameter, called w [21] . The distribution of points on the "diagnostic surface" was characterized by several frequency peaks ( Figure 1A ). These selections contained combinations of the four markers transformed into a single variable dependent on age, see sketch in Figure 1B [22, 23] .
The vertical distance between the tested measurements and the reference level (the most frequent metabolite combination at mature age) was called the combined indicator of vitamin B 12 status (cB 12 ). Its values were previously interpreted as high-normal (+0.4), normal (0), low-normal (-0.5), deficient (-1.5) and severely deficient (-2.5). The effect of age on the combined variable was assessed [22, 23] , and the reference level was described by an equation [23] instead of a fixed value [21] . This approach was validated using two physiological characteristics moderately affected by B 12 status: hemoglobin and cognitive score [23] .
Despite a higher reliability of the four-marker analysis, the routine measurements usually include only two or three tests due to the lower overall costs. This restriction apparently precludes calculation of the four-component indicator and complicates comparison of the diagnostic results based on different markers.
This article addresses the above issues. First, we suggest a method for calculating the combined indicator of B 12 status (cB 12 ) when one or two biomarkers are missing. Second, we examine the effect of folate status on cB 12 since folate affects tHcy (one of the four components of cB 12 ). Finally, the gradation of cB 12 status is revised, and useful cut-points are proposed.
Materials and methods

Theory
The four-component indicator w was previously called the "wellness parameter" [21, 23] or "wellness score" [22] . Now we have replaced this term by a more descriptive definition, "combined indicator of vitamin B 12 status" or "cB 12 
The first element of Equation 1 represents the logarithmic ratio of test measurements, and the second element is a reference combination at the stipulated age. Further details of the original formula have been presented elsewhere [21, 23] . [24] [25] [26] [27] [28] [29] [30] [31] [32] or obtained from the literature [33] . The database included apparently healthy volunteers (n = 76) from Aarhus, Denmark [24] ; subjects from Aarhus (n = 647) suspected to be B 12 deficient [25] ; healthy vegans from Britain (nv144) without any serious medical disorders [26] ; elderly people (n = 946) from Banbury (Oxfordshire, England) [27] ; Hispanic elderly (n = 665) participants in the Sacramento Area Latino Study on Aging (SALSA) who were exposed to mandatory folic acid fortification and in some cases to folic acid supplementation [28] ; community-dwelling elderly (n = 320) from Santiago, Chile, classified as having adequate, marginal and deficient B 12 status based on serum B 12 measurement who were consuming folic acid fortified bread [29, 30] ; young adults (n = 2439) recruited at the University of Dublin, Ireland [31] ; community living Mexican adult women (n = 128) who were exposed to mandatory folic acid fortification [32] ; and finally US subjects with folate (n = 19) or B 12 deficiency (n = 72) confirmed both biochemically and clinically [33] . The adjustment for serum folate was examined in 972 individuals who had data on this variable.
Eligibility criteria
Data were excluded from subjects with: 1) plasma creatinine > 100 μmol/L; 2) holoTC concentrations beyond the reliable range of 1-500 pmol/L; and 3) total B 12 > 1000 pmol/L. If interventions were conducted, only baseline values were included. All the subjects were apparently healthy, except for those with confirmed folate or B 12 deficiency.
Standardization of units
Concentrations of biomarkers were standardized to: 1) pmol/L for B 12 and holoTC; 2) μmol/L for tHcy and MMA; and 3) nmol/L for serum folate.
Calculation of combined B 12 status in the absence of one or two biomarkers
We used the "pooled database" (containing the results of all four tests) to predict each biomarker considered to be missing. Its logarithmic concentration (Z) was plotted versus the logarithmic combination of the three other markers (X) and age (Y) (Figure 2A ). The points obtained were initially approximated by the linear surface Z theor = A 1 +A 2 ·X+A 3 ·Y. It was then supplemented by trial elements (e.g., A 4 ·X·Y, A 4 ·X 2 , etc.) that affected the goodness of fit. The best additional expression (if any) was included into the final equation. Refinement was continued until the linear slope of the verification plot Z real versus Z theor (e.g., Figure 2B ) deviated from unity by < 5·10 -6 . The value of Z theor filled a "gap" in Equation 1 and allowed assessment of the "incomplete" three-component indicator 3cB 12 calculated from the three known measurements and the prediction (inserted into Equation 1 instead of the absent value). Analogous logic was applied to calculation of 2cB 12 based on two known markers and prediction for the other two missing values expressed, e.g., as log 10 (holoTC/ MMA).
The initial estimates of 3cB 12 and 2cB 12 were subjected to additional correction to compensate for a systematic deviation. The problem lies in the least squares estimate of Z theor in Figure 2A , which does not consider an error of the "independent" variable X. This introduces a small systematic deviation to Z theor ( Figure 2B ) and to the corresponding values of 3cB 12 or 2cB 12 ( Figure 2C ). The deviation was corrected using dependence of 3cB 12 (or 2cB 12 ) on 4cB 12 ( Figure 2C ). This linear chart has no pre-defined x-axis, and both 3cB 12 and 4cB 12 can be assigned as the apparent "independent" variable x. If x = 3cB 12 and y = 4cB 12 the line y = A 1 +A 2 ·x has by definition the intercept A 1 = 0 and the slope A 2 = 1 (fitting method 0). Swapping of coordinates (x = 4cB 12 , y = 3cB 12 ) changes the best fit to, e.g., A 1 = 0.14, A 2 = 0.96 (fitting method 1). The intermediate line between the two above fittings represents total least squares fit and has the intermediate linear parameters of A 1 = 0.07, A 2 = 0.98 (fitting method 2). Three sets (0, 1 and 2) of the correction coefficients A 1 and A 2 were used to adjust cB 12 :
The effect of each correction was examined on the residual plot (see an example in Figure 2D ).
Correction of the combined indicator for folate status
Low folate status is expected to increase tHcy thereby shifting cB 12 downward. The folate effect can be expressed as Δ folate = log 10 (Hcy real / Hcy theor ), where Hcy real refers to an observed measurement at any folate status and Hcy theor is a theoretical prediction expected at the normal plasma folate concentration (see entries 3 and 4 in Table 1 ). One of the folate datasets had no measurements of holoTC [33] , and its Hcy theor was calculated from MMA and B 12 (entry 4 in Table 1 ). Successful correction, however, requires independence of the other markers of folate.
Cut-points of the combined indicator of vitamin B 12 status
Five categories of B 12 status ( Figure 1A ) were used to calculate the values of cB 12 and plot them as probability density functions with the same normalized area. The intersections show the optimal cut-points [34] . Selections of cB 12 above and below -0.5 ( ± 0.1, ± 0.5) were compared in terms of hemoglobin (Hb) and cognitive score 0%-100% (mini mental state examination [27] and global cognitive score [28, 29] ) as surrogates for hematological status and cognitive function, respectively.
Results
Assessment of combined vitamin B 12 status in the absence of individual biomarkers
HoloTC is one of the most frequently absent biomarkers; therefore its prediction is described in the most detail. The logarithmic concentrations of holoTC were taken from the four-marker database and plotted versus the three other markers X and age Y (Figure 2A ). The points were approximated by a theoretical surface Z theor as explained in the Methods. The final approximating equation is presented in Table 1 (entry 2). Figure 2B validates accuracy of this function by showing the linear chart of real holoTC versus theoretical holoTC (slope of 1.0000000003). It appears, however, that this chart has dispersion along both axes, as in the sketch shown in the lower inset of Figure 2B . Dispersion of theoretical holoTC in Figure 2B was encoded during the least squares fit in Figure 2A , where the error associated with combination of three markers could not be considered. This caused a skewed dispersion of points in Figure 2B (main chart and lower inset) leading to a systematic deviation of the fitting line. The contrary situation (with purely vertical dispersion and a "perfect" fit) is depicted in the upper sketch of Figure 2B for a comparison.
To correct deviation, the three-component indicator 3cB 12 (derived from observed B 12 , MMA, tHcy and theoretical holoTC) was aligned with the true four component 4cB 12 in Figure 2C . Depending on the assumed coordinate x the best linear fit changes its position: fit "0" for x = 3cB 12 (dashed line); fit "1" for x = 4cB 12 (dotted line); fit "2" for the average situation of total least squares (solid line). Assuming one or another set of linear fitting coefficients, we have calculated three variants of the corrected indicator cB 12 (Equation 2) . Deviation between the real 4cB 12 and the predicted value of cB 12 was examined on the residual plot ( Figure 2D ). The average dispersion around zero (σ cB12 ) of green points (fit "1") and blue points (fit "2") increased by 4% and 0.9%, respectively, when compared with red points (fit "0"). Blue and green points showed the lowest systematic shifts based on spline approximations. Based on these observations, procedure "2" was chosen as the preferable method to adjust prediction for the "incomplete" cB 12 .
The same methodology was repeated for the other three markers, see the Supplementary Material (Figures S1-S10 and Table S2 ). The suggested predictive functions for the markers and the corresponding correction equations of 3cB 12 and 2cB 12 are shown in Table 1 . The low average dispersion of points around zero in the residual charts (σ cB12 column in Table 1 ) reveals the most reliable The average deviation of the predicted "incomplete" cB 12 from the true values obtained in the complete four-variable test. The span 0 ± σ cB 12 covers 68% of all the points. Low σ cB 12 deviation means better correspondence with the full test.
marker combination in the "incomplete" tests (see the Discussion).
Correction of combined vitamin B 12 status for folate status
Assessment of the folate-associated shift in cB 12 was done as explained in Methods. The amplitude of shift Δ folate = log 10 (Hcy real /Hcy theor ) showed a steep increase at folate concentrations < 10 nmol/L ( Figure 3A) . The combination of the three other markers (excluding tHcy) was, in contrast, essentially independent of serum folate ( Figure 3B ). This means that only tHcy requires correction. The data in Figure 3A were used to obtain the empirical correction (Equation 3) for the folate-associated shift: 
Similar correction using red blood cell (RBC) folate failed, because changes in RBC folate considerably affected the ratio of the three other markers making correction impossible (data not shown). This is not surprising, since red blood cell folate is known to be influenced by B 12 status [5] .
Cut-points of combined vitamin B 12 status
Five areas in Figure 1A covered the major Gaussian peaks and their age-related shifts: area 1 with borders of (holoTC·B 12 12 were extracted from these regions and presented as probability distributions ( Figure 4A ). The points of their intersection indicate the approximate borderlines. The main distributions in Figure 4A cover cB 12 values from -5 to 1. A small distribution above 1.5 (n = 44, not shown) was classified as "elevated vitamin B 12 " (supra-physiological B 12 ), see also Table  2 . The two dominating peaks, 1 and 2 (prevalent in young and adult cohorts) were pooled together and regarded as the "adequate vitamin B 12 status" category (cB 12 from -0.5 to +1.5). Peak 3 has intermediate characteristics and noticeably overlaps peak 2. We decided to treat the interval of cB 12 from approximately -1.5 to -0.5 as indicating "low vitamin B 12 ". The main part of distribution 4 was classified as a group with "possible B 12 deficiency" (cB 12 from -2.5 to -1.5). Finally, the broad peak 5 (cB 12 < -2.5) was categorized as the group with "probable B 12 deficiency".
The gray zone in Figure 4A represented a transitional region around the general cut-point of -0.5, where identification of B 12 status might be ambiguous. We considered a broad zone (cB 12 = -0.5 ± 0.5) and a narrow zone (-0.5 ± 0.1). The measurements of hemoglobin and cognitive score were selected to the left and to the right of these diffuse separators and presented as the corresponding distributions. The selections with adequate status (above separator) had better physiological characteristics ( Figure 4B , C red lines) if compared with the selection having possible/probable B 12 deficiency (below separator, green lines). Differences were highly significant according to Kolmogorov-Smirnov and Kruskal-Wallis non-parametric tests. A sharp separator at cB 12 = -0.5 gave a decreased level of significance for hemoglobin and ambiguous results for cognitive function, balancing at the border of significance. Table 2 provides a summary description of suggested classifications of B 12 status together with guidelines for further application of this approach.
Discussion
Assessment of combined vitamin B 12 status with missing markers
The method presented enables calculation of the "incomplete" three-component indicator 3cB 12 and the twocomponent indicator 2cB 12 . Both types of analysis are economically advantageous due to their lower laboratory costs (compared with the four-marker procedure). Table 1 shows the equations necessary for calculation of 3cB 12 and 2cB 12 , and we also provide spreadsheets in the Supplemental Materials to simplify calculations. It should be understood that measurement of all four markers gives more reliable determination of B 12 Figure 1A . Approximate gradation of status is notated at the top. Gray shading indicates a zone with potentially ambiguous diagnostics. General cut-point of -0.5 is proposed. (B) Distributions of hemoglobin from the selection with cB 12 > 0 or -0.4 (red line) and cB 12 < -1 or -0.6 (green line). Significance of difference was judged by Kolmogorov-Smirnov (**) and Kruskal-Wallis (***) tests, see also [23] . (C) Distributions of cognitive score. Selections and significance (*** by K-S test, ** by K-W test) were obtained as in panel B, see also [23] .
still represents an improvement on one biomarker tests. Table 1 classifies the "incomplete" tests according to their reliability (lower σ cB12 = greater reliability). The best simulation of the full-scale procedure was obtained with B 12 , holoTC and MMA measured (tHcy excluded), see entry 3. The next best simulation was shared by two tests of almost equal precision: without B 12 (entry 1) or without holoTC (entry 2). Two-variable indicators expectedly showed a higher deviation (σ cB12 ). The smallest error was observed for the test based on holoTC and MMA (entry 8).
The errors of ± 0.25 are apparently acceptable considering the span of status groups in Figure 4A , e.g., "adequate B 12 " from -0.5 to 1.5.
Correction of the combined indicator of vitamin B 12 status by folate status
The combined indicator cB 12 needs adjustment when serum (plasma) folate is below 10 nmol/L and calculations include tHcy. Correction by RBC folate was impossible because of changes in all markers. B 12 deficiency causes accumulation of methyl folate with increased plasma folate levels and reduced red cell folate [35] . Correction for low folate should therefore be omitted if interactions between folate and B 12 status are at issue. The influences of molecular genetic determinants, such as polymorphisms, were not included in our models, but represent a potential topic to be explored in the future.
Cut-points and guidelines for using the combined indicator of vitamin B 12 status
In the present study, we define cut-points from statistical criteria and physiological indicators based on hemoglobin and cognitive score. However, it is important to acknowledge that both indicators depend on many factors apart from B 12 status. Yet, even this rough approach indicated changes in the selections above and below the "gray zones" of cB 12 (Figure 4) . The diffused separators were used to highlight the artificial character of the sharp cut-point (cB 12 = -0.5) and to estimate its possible error (assessed as a value between ± 0.1 and ± 0.2). Further research is planned to connect the combined indicator with other pathophysiological manifestations of B 12 deficiency.
For researchers and clinicians we suggest classification of B 12 status as "elevated vitamin B 12 ", "vitamin B 12 adequacy", "low vitamin B 12 ", "possible vitamin B 12 deficiency" and "probable vitamin B 12 deficiency" ( 12 adequacy" ( > 221 pmol/L), "low B 12 " (between 148 and 221 pmol/L) and "B 12 deficiency" ( < 148 pmol/L) [37] . The approximate correspondence of these categories to our novel approach can be achieved at cB 12 > -0.5; -2.5 < cB 12 < -0.5; and cB 12 < -2.5, respectively.
The individual markers (constituting cB 12 in Table 2 ) are not identical with the combined indicator itself. For example, the students of Trinity college [31] with low B 12 status included 13.7% and 6.7% based on B 12 < 186 pmol/L and cB 12 < -0.5, respectively. Here the result of the combined analysis seems to be more realistic.
Potential uses of the combined indicator of vitamin B 12 status
One combined indicator (calculated form several measurements) allows for more reliable diagnostics compared with any single biomarker. In this way detection of subclinical B 12 deficiency can be improved. Calculation of "incomplete" cB 12 rescales data, based on unmatched marker combinations, into a universal coordinate system, thereby simplifying comparison of the results. A "higher weight" of cB 12 in terms of accumulated information might help to validate the conventional cut-points of the individual markers and expose functional consequences of low B 12 status. At the epidemiological level, there is the potential to better define: 1) the consequences of clinically undetected B 12 deficiency; and 2) the magnitude of B 12 deficiency as a public health problem.
Limitations
The databases used here and earlier [21, 23] are heterogeneous in both participants and methods. Therefore, the statistical estimates obtained from our pooled database are potentially affected by multiple sources of variation.
The definition of cut-points needs further revision based on clinical and functional manifestations of B 12 deficiency. As there were no children in any of datasets, we currently limit application of our approach to individuals above 18 years of age. Since plasma B 12 , tHcy, and MMA concentrations are altered during pregnancy [38, 39] this should also be taken into account.
Future perspectives
The next step should be validation of the cut-points in the context of functional B 12 deficiency. Further experience is required to establish whether this approach can become a standard tool for more accurate determination of B 12 status, as well as evaluating the response to B 12 supplementation.
Conclusions
We provide equations and spreadsheets that combine two, three or four biomarkers into one diagnostic parameter called "combined indicator of vitamin B 12 status". Adjustment of this indicator is required at serum or plasma folate < 10 nmol/L because of increase in tHcy. Revised cut-points and guidelines for the novel approach are suggested.
